期刊文献+

生长激素释放因子在CHO细胞的表达 被引量:4

Expression of Growth Hormone Releasing Factor in CHO Cells
下载PDF
导出
摘要 在对生长激素释放因子 (GRF)基因改造和化学合成 ,并构建了其真核表达载体 pc DNA3- GRF(1- 32 )的基础上 ,用 L ipofectin将上述载体转染 CHO细胞进行瞬时表达。提取转染细胞总 RNA,用 RT- PCR和 Dot blotting检测 GRF基因的表达情况 ,用 Western blotting检测转染细胞上清液的表达产物 ,均得到了阳性结果。制备大鼠垂体单层细胞 ,测定表达产物的生物学活性 ,结果表达产物可刺激生长激素释放 ,并且比对照组提高 3.8倍。试验结果表明 ,已构建的真核表达载体 pc DNA3- GRF(1- 32 )能表达出有生物学活性的 GRF。 Chemical synthesis of the GRF(1 32) gene has been finished in our former work.This GRF(1 32) gene has been inserted into a plasmid, pcDNA3, to construct an expression vector.In this study, pcDNA GRF(1 32) is expressed in CHO cells.The expression vector was purified with a High Pure Plasmid Extraction Kit and then transfected into prepared CHO cells in 60% confluent.The expression of GRF(1 32) was detected by RT PCT with a pair of 23 bp primers, followed by Dot blotting with a synthesized (83 nt) probe, which had been radioactively labelled with 32 P with T4 polynucleotide kinase.Positive results were obtained.Supernatant of transfected CHO cells was analyzed with Western blot, whose result showed a special GRF band.Dispersed rat pituitary were used to determine the activity of expressed GRF(1 32).Results showed that the expressed products stimulated Growth Hormone(GH) secretion by pituitary cells at levels which were 3 8 folds higher than the control group.The results in this study indicate that we have constructed GRF eukaryotic expression vector successfully.
出处 《中国兽医学报》 CAS CSCD 北大核心 2002年第1期53-55,共3页 Chinese Journal of Veterinary Science
基金 国家自然科学基金资助项目 (3 95 0 0 10 5 )
关键词 GRF CHO细胞 真核表达 GRF CHO cell eukaryotic expression
  • 相关文献

参考文献1

二级参考文献1

  • 1卢圣栋,现代分子生物学实验技术,1993年,73页

共引文献7

同被引文献25

  • 1任晓慧,张永亮,刘松财,戴建威.微球包裹pcDNA3-GRF(1-32)在小鼠肌肉组织的表达及对生长的影响[J].生物工程学报,2004,20(4):615-618. 被引量:15
  • 2王杨,黄会岭,孙宝忠,刘艳军,孟庆勇.外源GHRH基因质粒对犊牛免疫功能的影响[J].湖北畜牧兽医,2007,28(3):8-10. 被引量:3
  • 3Andersan W E. Human gene therapy. Nature, 1998,392:25 -- 30.
  • 4Mahato R I, Rolland A, Tomlinson E. Cationic lipidbased gene delivery systems: pharmaceutical perspectives, Pharm Res, 1997(14) : 853 -- 859.
  • 5Aspden T J, Mason J D, Jones N S. Chitosan as a nasal delivery system: the effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers.Pharm Sci, 1997,86:509--513.
  • 6Sugana M, Fujikawa T, Hiratsuji Y, et al. A novel use of chitosan as a hypocholesterolemic agent in rats American Journal of Cain.Nutrition, 1980,4:787 -- 793.
  • 7Zhengrong C, Russell J M. Chitosan-based nanopartieles for topical genetic immunization. Journal of Controlled Release, 2001, 75:409 - 419.
  • 8Rasmussen R, Morrison T, Herrmann M, et al. Quantitative PCR by continuous fluorescence monitoring of a double strand DNA specific binding dye. Biochemical, 1998,2:8 - 11.
  • 9Sato T, Shirakawa N, Nishi H, et al. Formation of a DNA/polygalactosamine complex and its interaction with cells, Chem Lett, 1999,26:725 - 726.
  • 10Luo D, Saltzman W M. Synthetic DNA delivery systems. Nat Biotech,2000, 18:33 -- 37.

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部